Cipher Pharmaceuticals Inc is making waves on the TSX with a notable gain.
Cipher Pharmaceuticals Inc (CPH.TO) is experiencing a positive surge in its stock price, rising by 4.55% in today's trading session, bringing its share price to CA$17.69. This upward movement highlights investor confidence in the company's recent performance.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$431.55M
P/E
10.2x
52W high
$20.56
52W low
$12.48
1W change
+3.42%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 22.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+22.0% Upside
Current Price
C$16.92
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
19.9%
Annualized
90-Day Vol
32.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$14.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.94 | C$14.89 – C$17.07 |
| 60 trading days | C$15.02 | C$13.63 – C$16.55 |
| 90 trading days | C$14.15 | C$12.57 – C$15.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a strong profit margin of 60.6% and a P/E ratio of 10.13, Cipher Pharmaceuticals is showing robust financial health, making it an attractive option for investors looking for growth in the pharmaceutical sector.
4.55% Gain in One Day
Cipher Pharmaceuticals' stock has risen significantly today, reflecting strong investor sentiment and confidence in its market position.
Bull case
The recent increase in stock price shows that investors are optimistic about Cipher Pharmaceuticals' financial performance, especially after its impressive revenue growth in previous quarters. This could signal ongoing strength in operations and potential for future profits.
Bear case
Despite the positive movement, it's wise for investors to stay cautious. The lack of recent news or announcements might lead to volatility, and potential market corrections could affect the stock's performance soon.
Advertisement
Strong Financial Performance
Cipher Pharmaceuticals has consistently reported impressive financial results, including a net income of CA$6.2 million for Q1 2026, a remarkable 135% increase from the previous year. This strong performance is likely contributing to the stock's rise today.
Market Sentiment and Future Outlook
The positive movement in Cipher Pharmaceuticals' stock price today may also be due to favorable market sentiment surrounding the pharmaceutical sector. Investors are increasingly optimistic about the company's ability to sustain growth and profitability in the coming quarters.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
